50fold

50Fold's audit of Tennr, graded from public info for our breakdown. The company didn't ask for it or answer our questions.

LeaderboardGet your free audit
Free 50Fold Startup Audit

Tennr

50Fold Score76/100
Grade B
Get your free audit

Everything rests onReferral-driven providers will pay for software that converts more faxed referrals into paid orders without hiring more intake staff.

Top suggestionSize each segment by referral volume and spend

50Fold's specialists read 4 pages and checked 17 findings for this audit.

Your 7 grades, weakest first

  1. C

    Market size (bottom-up)

    Finance (CFO)

    50Fold sizes the reachable market at about 11K DME and infusion providers, worth about $550M a year at an estimated $50K contract, with a 1-3 year share near 550 providers or $27.5M a year. The contract price and infusion count are 50Fold's estimates, so the sizing is uncertain. (thin basis)

    50Fold's bottom-up market sizelow confidence
    1. Total market (TAM)$3B/yrestimate
    2. Market you can reach now (SAM)$550M/yr
    3. Realistic share in 1–3 years (SOM)$28M/yrestimate
    How we sized it
    • Total market: Everyone who could ever buy this × your price≈60K U.S. provider organizations that receive referrals (DME, infusion, specialty practices, fertility, pharmacies) × $50,000/yr
    • Market you can reach now: The buyers you can actually reach today × your price≈11K DME/HME supplier locations and infusion providers × $50,000/yr(AAHomecare estimate of traditional Medicare DMEPOS locations, 2024)
    • Realistic share in 1–3 years: The buyers you could realistically win first × your price≈550 provider organizations × $50,000/yr
    • Total market: TAM: assumes about 60K U.S. referral-receiving provider organizations, each paying a ~$50K yearly contract; price is 50Fold's estimate
    • Market you can reach now: SAM: ~8,000 Medicare DMEPOS locations (AAHomecare, 2024) plus an assumed ~3,000 infusion providers
    • Realistic share in 1–3 years: SOM: 5% of SAM in 1-3 years, above the usual range given national customers and case studies
    • Rests on a ~$50K yearly contract per provider organization, which Tennr does not publish; large national suppliers likely pay far more.
    How to raise your score
    1. Widen to specialty pharmacies and hospital systems, both already on the site, each sized by count and referral volume.
    2. Niche first to large respiratory and sleep DME suppliers like Lincare and Apria, where fax volume and denial costs are highest.
    3. Price per referral processed, so yearly value grows with each provider's volume rather than a flat contract.
    📊 50Fold Finance (CFO) can:

    Model TAM, SAM and SOM per segment (DME, infusion, specialty pharmacy, hospitals) in a financial model, with counts and contract sizes, to pick the next segment.

    Get your free audit
  2. C

    Offer and price

    Finance (CFO)

    There is no price anywhere: every path leads to a demo, and the offer starts with a process analysis that sizes the revenue impact. A buyer can't compare the cost with Parachute Health, a DME ordering network, or with intake staff who take up to 70 minutes per referral. (your site)

    How to raise your score
    1. Publish a price model: per referral processed, with a starting monthly minimum, set against the staff cost per referral.
    2. Sell the process analysis as a paid pilot credited to year one, so buyers commit before full rollout.
    3. Add a plan per segment: DME intake plus resupply, infusion intake plus prior auth, each with its own unit price.
    📊 50Fold Finance (CFO) can:

    Model per-referral pricing against staff cost per referral in a pricing model, and write a pilot offer and price line for your segment pages.

    Get your free audit
    Evidence (1)
    “Every relationship begins with in-depth process analysis that finds your biggest opportunities for improvement and sizes the revenue impact.”
    Linked page
  3. B

    Edge vs alternatives

    Marketing (CMO)

    The site names the alternative buyers use now, their own intake specialists, and claims Tennr is faster with case numbers like 75% faster referrals at 4x volume. It never names Parachute Health or Calvient, which compares itself directly with Tennr, so buyers can't see the difference before a demo. (your site)

    How to raise your score
    1. Answer Calvient's comparison page with a Tennr vs Calvient page on payer-criteria coverage and prior auth submission.
    2. Position against Parachute Health: Tennr works with any fax or portal, so suppliers needn't wait for prescribers to join a network.
    3. Publish one checkable number per segment, like first-pass denial rate before and after, from named customers.
    📣 50Fold Marketing (CMO) can:

    Create Tennr vs Calvient and Tennr vs Parachute Health pages on your website to answer buyers' questions and help AI chats recommend you.

    Get your free audit
    Evidence (2)
    “Tennr pulls data from faxes, charts, and insurance plans faster than your best intake specialist, and can handle that volume without manual intervention.”
    Homepage
    “Home Medix Takes Referrals 75% Faster Than Before with 4X the Volume”
    Homepage
  4. B+

    Problem pain

    Product (CPO)

    The site states the pain plainly: missing documentation is the top reason patients stall, and every unconverted referral is lost revenue. A buyer at King Drug describes 260 faxes in a day, but the site never puts a dollar cost on today's workaround of hiring more intake staff. (your site)

    How to raise your score
    1. Put a cost on the workaround: intake staff at up to 70 minutes per referral, priced per 1,000 referrals, on the DME page.
    2. Lead with the backlog moment in a buyer's words: the 3-week backlog story, told by the intake manager who lived it.
    3. Lead the product with missing-document retrieval, the stated #1 stall cause, and show its completion rate.
    🧭 50Fold Product (CPO) can:

    Write a pain-led page for DME intake leaders with the cost of manual intake per 1,000 referrals and a backlog story in the customer's own words.

    Get your free audit
    Evidence (3)
    “Missing documentation is the #1 reason patients stall.”
    Homepage
    “Every unconverted referral is permanent revenue loss.”
    Linked page
    ““We hit 260 faxes in one day… and were able to manage it.””
    Homepage
  5. B+

    Path to customers

    Sales (CRO)

    A visitor can book a demo next to testimonials and case studies, and a webinar on fertility's shift to insurance pulls in a new segment. Referrer visibility doubles as a channel, since referring offices see Tennr on every order, but no outbound motion to named suppliers is visible. (your site)

    How to raise your score
    1. Run outbound to large respiratory suppliers like Lincare and Apria with a free referral-backlog analysis.
    2. Pitch national infusion providers like Option Care Health on a site-level pilot measured on days from script to seat.
    3. Partner with DME manufacturers to offer Tennr to their supplier networks, since manufacturers are already a named segment.
    🤝 50Fold Sales (CRO) can:

    Build a list of DME and infusion providers like Lincare, Apria and Option Care Health, write the outreach, and set it up in your CRM and email with weekly tracking.

    Get your free audit
    Evidence (2)
    “Join us Nov. 3 for a live webinar on fertility's shift from self-pay to insurance”
    Homepage
    “Delight your referrers by giving them real-time visibility into script status and to-dos for every patient. They’ll remember it when they’re prescribing.”
    Homepage
  6. A-

    Customer clarity

    Product (CPO)

    The site names six buyer types with their own pages, and each page states a job: DME suppliers scale referral and resupply work without adding staff, and infusion providers learn at intake whether they can treat a referred patient. Fertility clinics and hospitals are listed, but their jobs weren't in the pages read. (your site)

    How to raise your score
    1. Name the buyer role per segment: 'For DME intake directors' and 'For infusion access managers', with the metric each owns.
    2. Route demo requests by segment and monthly referral volume so each buyer meets a specialist for their workflow.
    3. Decide which segment's job comes next on the roadmap: fertility's shift to insurance needs benefits checks, so package that first.
    🧭 50Fold Product (CPO) can:

    Write a buyer-role line and owned metric for each segment page on your website, and a demo form that routes by segment and referral volume.

    Get your free audit
    Evidence (2)
    “Tennr helps DME suppliers and manufacturers improve, scale, and accelerate complex inbound referral and resupply workflows without adding staff.”
    Linked page
    “Tennr helps infusion providers instantly learn if they can actually treat a referred patient, then moves eligible patients through pre-visit processing quickly and accurately to minimize denials and drop-offs.”
    Linked page
  7. A

    Proof so far vs stage

    Product (CPO)

    Providers pay and see results: named customers report outcomes like same-day intake from a 3-week backlog, and the founder's answers cite a $101M Series C. What the site doesn't show is retention or how many sites each customer expands to. (your answer)

    How to raise your score
    1. Publish a case study with revenue: referrals converted and dollars collected per month, before and after Tennr.
    2. Track and share expansion proof: share of customers adding resupply or prior auth after intake, for enterprise sales.
    3. Interview 15 providers who ran the process analysis but didn't buy, to learn what blocked the contract.
    🧭 50Fold Product (CPO) can:

    Write an interview script for providers who saw the analysis but didn't buy, set up the outreach in your email, and turn the patterns into case studies.

    Get your free audit
    Evidence (1)
    “From a 3-week backlog to same-day patient intake”
    Homepage

Top suggestions

Suggestion 1 · Start here

Size each segment by referral volume and spend

The market sizing rests on an estimated $50K contract and an assumed infusion count, with no published price.

📊 50Fold Finance (CFO) can:

Find 20 intake leaders across segments, send the interview invite from your email, and model per-segment market size from the answers weekly.

Get your free audit
Done for you: interview questions

Ask intake leaders at DME, infusion and specialty pharmacy providers, found through AAHomecare and NHIA member lists:

How many referrals did you receive last month, and how many by fax?

How many staff hours went into intake last week?

What share of referrals never became a delivered order or a started therapy?

What did your last first-pass denial cost you?

When did you last add intake headcount, and why?

What do you pay today for any intake software or outsourced staff?

Experiment
Experiment
Interview intake leaders at 20 providers across DME, infusion and specialty pharmacy about referral volume, staff cost and denial losses, then rebuild TAM and SAM per segment.
Go if
One segment shows yearly intake cost above $250K per provider in 8 of 20 interviews, making it the next focus.
Stop if
No segment shows a consistent cost pattern across at least 5 interviews.
Suggestion 2

Win large respiratory suppliers with a backlog analysis

Lincare and Apria run respiratory and sleep supply at national scale, where fax volume and denials are highest.

🤝 50Fold Sales (CRO) can:

Find 25 large DME suppliers like Lincare and Apria, send the analysis offer from your inbox once you OK the first, and track replies and pilots in your CRM weekly.

Get your free audit
Experiment
Experiment
Offer 25 large DME suppliers, starting with Lincare and Apria, a free 2-week referral backlog analysis sizing revenue lost to unconverted referrals, then a paid pilot at one site.
Go if
6 or more accept the analysis and 2 sign a paid pilot within 90 days.
Stop if
Fewer than 3 of 25 accept after two follow-ups.
Suggestion 3

Answer Calvient and Parachute Health by name

Calvient publishes a direct comparison saying Tennr's scope ends at the referral inbox, and Tennr names no rival on its site.

📣 50Fold Marketing (CMO) can:

Build the comparison pages, publish them on your website, send them to open opportunities from your CRM, and track competitive win rates weekly.

Get your free audit
Experiment
Experiment
Publish Tennr vs Calvient and Tennr vs Parachute Health pages showing prior auth, resupply and denial results from named customers, and send them to all open opportunities.
Go if
Win rate in deals where a rival is named rises 10% or more within a quarter.
Stop if
Win rate moves less than 3% after 30 competitive deals.

Founding members get early access on Nov 30, 2026.

Competition 3 rivals checked

Parachute HealthWins for suppliers whose referrals still arrive by fax or portal, since Tennr works from any source; Parachute is stronger when prescribers already order in its network.

Who it's forDigital ordering network connecting prescribers and DME suppliers so orders arrive clean without fax back-and-forth.

StrengthSuppliers receive clean orders directly from prescribers.

Where you winWins for suppliers whose referrals still arrive by fax or portal, since Tennr works from any source; Parachute is stronger when prescribers already order in its network.

Sourcesparachutehealth.com (strength, who it's for)

CalvientWins on depth for DME and infusion intake with payer criteria and prior auth; Calvient claims broader coordination beyond the referral inbox.

Who it's forAI for healthcare teams covering referral routing and coordination beyond the inbox; compares itself directly with Tennr.

Where you winWins on depth for DME and infusion intake with payer criteria and prior auth; Calvient claims broader coordination beyond the referral inbox.

Sourcescalvient.com (who it's for)

Manual referral intake staffWins for high-volume providers where staff take up to 70 minutes per referral and backlogs build, as in the 3-week-to-same-day case.

WeaknessSlow: up to 70 minutes of staff time per referral.

Where you winWins for high-volume providers where staff take up to 70 minutes per referral and backlogs build, as in the 3-week-to-same-day case.

Sourcesmedicaleconomics.com (weakness)

SWOT

Strengths

  • A payer-criteria library and prior auth submission go past intake, so Tennr can claim revenue outcomes, not just time saved. (Problem pain)
+2 more
  • Segment pages with distinct jobs let sales speak to DME, infusion and fertility buyers in their own terms. (Customer clarity)
  • Referrer visibility puts Tennr in front of prescribing offices on every order, a built-in channel. (Path to customers)

Weaknesses

  • No published price makes every deal start with a demo and analysis, slowing smaller suppliers. (Offer and price)
+2 more
  • No public comparison with named rivals leaves buyers to rely on rivals' own comparison pages. (Edge vs alternatives)
  • Market size rests on estimated contract values, making expansion targets hard to set. (Market size (bottom-up))

Opportunities

  • Manual intake takes up to 70 minutes per referral, so a per-referral price beats staff cost on a clear number. medicaleconomics.com
+2 more
  • Large respiratory suppliers like Lincare and Apria receive high referral volumes, so one win can carry many sites. lincare.com
  • Fertility's shift from self-pay to insurance creates new benefits-checking work Tennr already does elsewhere. (Customer clarity)

Threats

  • Parachute Health routes clean DME orders straight from prescribers, which could make faxed referrals rarer for suppliers. parachutehealth.com
+2 more
  • Calvient publishes a direct comparison saying Tennr's scope ends at the referral inbox, shaping how buyers see Tennr. calvient.com
  • Suppliers can keep adding intake staff instead, so Tennr must show cost per referral below a staffer's. medicaleconomics.com
50Fold's team can:

Turn this SWOT into a 30-day plan: a fix for each weakness, a test for each opportunity and a watch on each threat, with a weekly check-in.

Get your free audit

Research

Our recommendations improve with access to more of your company's info.

Companies that fit your buyer 3 companies

  • LincareLarge home respiratory supplier receiving high volumes of faxed referrals and orders.
  • ApriaRespiratory and sleep apnea supplier whose intake depends on referrals and payer qualification.
  • Option Care HealthNational infusion provider, a segment Tennr names, with referral-driven patient intake.
🤝 50Fold Sales (CRO) can:

Find the decision-maker at each company, write the outreach, and track replies in your CRM.

Get your free audit
Sources we read (11)
Show 8 things we couldn't see
  • We found no separate pricing page linked from your homepage.
  • Research found no published price for any rival, so your price isn't compared with a rival's.
  • No price or pricing model
  • No retention or expansion figures
  • No count of customers or sites
  • No comparison with Parachute Health or Calvient
  • No rival prices in the research
  • No sourced count of infusion providers